Reimbursed with a limitationOriginator productATC L04AA04

Grafalon

Grafalon is an originator product from Neovii Pharmaceuticals AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 421.45 to CHF 4'060.40 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Neovii Pharmaceuticals AG
ATC code
L04AA04
IT group
07.15 Immunosuppressive Stoffe
Active substances
Immunoglobulinum anti-thymocyticum cuniculi
Preparation type
Originator product
On the SL since
01/01/2025
Last price change
01/01/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Grafalon Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inf Konz 100 mg/5mlDurchstf 5 mlCHF 372.42CHF 421.4501/01/2025B7680524120014
Inf Konz 100 mg/5ml10 Durchstf 5 mlCHF 3'718.42CHF 4'060.4001/01/2025B7680524120021

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/01/2025

GRAFALON ist indiziert zur Prävention der Graft-versus-Host-Erkrankung (GVHD) in Kombination mit der Standardprophylaxe Cyclosporin A / Methotrexat bei SCT mit HLA-kompatiblen, nicht-verwandten Spendern bei Erwachsenen mit malignen hämatologischen Erkrankungen.
Die Verschreibung soll ausschliesslich von Ärzten verordnet werden, die über entsprechende Erfahrungen in der Anwendung von Immunsuppressiva im Rahmen von Organtransplantationen verfügen.
Vor Therapiebeginn muss eine Kostengutsprache des Krankenversicherers nach vorgängiger Konsultation des Vertrauensarztes eingeholt werden.

FOPH wordingValid from 01/01/2025

GRAFALON wird in Kombination mit anderen immunsuppressiven Medikamenten (z.B. Methylprednisolon, Prednison, Azathioprin, Cyclosporin A) zur Prophylaxe und Therapie der Abstossungskrise nach Organverpflanzungen eingesetzt.
Die Verschreibung soll ausschliesslich von Ärzten verordnet werden, die über entsprechende Erfahrungen in der Anwendung von Immunsuppressiva im Rahmen von Organtransplantationen verfügen.
Vor Therapiebeginn muss eine Kostengutsprache des Krankenversicherers nach vorgängiger Konsultation des Vertrauensarztes eingeholt werden.

FAQ

Is Grafalon covered by Swiss health insurance?

Yes, but only under conditions. Grafalon is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Grafalon cost in Switzerland?

The public price is the maximum price set by the FOPH and for Grafalon ranges from CHF 421.45 to CHF 4'060.40 per pack. The ex-factory price ranges from CHF 372.42 to CHF 3'718.42. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com